These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Mårtensson J, Steinherz R, Jain A, Meister A. Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8727-31. PubMed ID: 2813421 [Abstract] [Full Text] [Related]
5. Anticataractogenic property of gamma-glutamylcysteine ethyl ester in an animal model of cataract. Ohtsu A, Kitahara S, Fujii K. Ophthalmic Res; 1991 Nov; 23(1):51-8. PubMed ID: 1870842 [Abstract] [Full Text] [Related]
6. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Maitra I, Serbinova E, Trischler H, Packer L. Free Radic Biol Med; 1995 Apr; 18(4):823-9. PubMed ID: 7750805 [Abstract] [Full Text] [Related]
7. Depletion of brain glutathione in preweanling mice by L-buthionine sulfoximine. Slivka A, Spina MB, Calvin HI, Cohen G. J Neurochem; 1988 May; 50(5):1391-3. PubMed ID: 3361302 [Abstract] [Full Text] [Related]
9. Glutathione depletion in tissues after administration of buthionine sulphoximine. Minchinton AI, Rojas A, Smith KA, Soranson JA, Shrieve DC, Jones NR, Bremner JC. Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748 [Abstract] [Full Text] [Related]
10. Modifications in lens protein biosynthesis signal the initiation of cataracts induced by buthionine sulfoximine in mice. Calvin HI, Wu JX, Viswanadhan K, Fu SC. Exp Eye Res; 1996 Oct; 63(4):357-68. PubMed ID: 8944543 [Abstract] [Full Text] [Related]
14. Progressive modifications of mouse lens crystallins in cataracts induced by buthionine sulfoximine. Calvin HI, Patel SA, Zhang JP, Li MY, Fu SC. Exp Eye Res; 1992 Apr 15; 54(4):611-9. PubMed ID: 1623946 [Abstract] [Full Text] [Related]
15. Early epithelial lesions in cataracts of GSH-depleted mouse pups. Laver NM, Robison WG, Calvin HI, Fu SC. Exp Eye Res; 1993 Oct 15; 57(4):493-8. PubMed ID: 8282035 [No Abstract] [Full Text] [Related]
16. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Smith AC, Liao JT, Page JG, Wientjes MG, Grieshaber CK. Cancer Res; 1989 Oct 01; 49(19):5385-91. PubMed ID: 2766304 [Abstract] [Full Text] [Related]
17. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD, Friedman HS. Cancer Res; 1988 May 15; 48(10):2764-7. PubMed ID: 3359437 [Abstract] [Full Text] [Related]
18. The effect of L-buthionine-[S,R]-sulfoximine on the pancreas in mice. A model of weakening glutathione-based defense mechanisms. Lüthen RE, Neuschwander-Tetri BA, Niederau C, Ferrell LD, Grendell JH. Int J Pancreatol; 1994 Aug 15; 16(1):31-6. PubMed ID: 7528760 [Abstract] [Full Text] [Related]